Skip to main content
Veterinary Medicines

Rominervin 10 mg/ml Solution for Injection for Horses

Authorised
  • Romifidine hydrochloride

Product identification

Medicine name:
Rominervin 10 mg/ml Solution for Injection for Horses
Rominervin 10 mg/ml Injektionslösung für Pferde
Active substance:
  • Romifidine hydrochloride
Target species:
  • Horse
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Romifidine hydrochloride
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Meat and offal
        6
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM93
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:
  • Multi-pack with 6 boxes each containing 1 vial of 50 ml. Colourless type I glass vials closed with a coated bromobutyl rubber stopper and aluminium cap. One glass vial in a cardboard box.
  • Multi-pack with 6 boxes each containing 1 vial of 20 ml. Colourless type I glass vials closed with a coated bromobutyl rubber stopper and aluminium cap. One glass vial in a cardboard box.
  • Multi-pack with 6 boxes each containing 1 vial of 10 ml. Colourless type I glass vials closed with a coated bromobutyl rubber stopper and aluminium cap. One glass vial in a cardboard box.
  • Multi-pack with 10 boxes each containing 1 vial of 10 ml. Colourless type I glass vials closed with a coated bromobutyl rubber stopper and aluminium cap. One glass vial in a cardboard box.
  • Box with 1 vial of 50 ml. Colourless type I glass vials closed with a coated bromobutyl rubber stopper and aluminium cap. One glass vial in a cardboard box.
  • Box with 1 vial of 20 ml. Colourless type I glass vials closed with a coated bromobutyl rubber stopper and aluminium cap. One glass vial in a cardboard box.
  • Box with 1 vial 10 ml. Colourless type I glass vials closed with a coated bromobutyl rubber stopper and aluminium cap. One glass vial in a cardboard box.
  • Multi-pack with 10 boxes each containing 1 vial of 50 ml. Colourless type I glass vials closed with a coated bromobutyl rubber stopper and aluminium cap. One glass vial in a cardboard box.
  • Multi-pack with 10 boxes each containing 1 vial of 20 ml. Colourless type I glass vials closed with a coated bromobutyl rubber stopper and aluminium cap. One glass vial in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 838648
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0318/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 21/01/2019
Updated on: 18/04/2024

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 21/01/2019
Updated on: 18/04/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 21/01/2019
Updated on: 18/04/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."